OBERMANNOVÁ, Radka and Florian LORDICK. Management of Metastatic Gastric Cancer. Hematology-Oncology Clinics of North America. PHILADELPHIA: W B Sauders Co-Elsevier Inc., 2017, vol. 31, No 3, p. "469"-"+", 16 pp. ISSN 0889-8588. Available from: https://dx.doi.org/10.1016/j.hoc.2017.01.006.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Management of Metastatic Gastric Cancer
Authors OBERMANNOVÁ, Radka (203 Czech Republic, guarantor, belonging to the institution) and Florian LORDICK (276 Germany).
Edition Hematology-Oncology Clinics of North America, PHILADELPHIA, W B Sauders Co-Elsevier Inc. 2017, 0889-8588.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30204 Oncology
Country of publisher United States of America
Confidentiality degree is not subject to a state or trade secret
Impact factor Impact factor: 3.098
RIV identification code RIV/00216224:14110/17:00100258
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.1016/j.hoc.2017.01.006
UT WoS 000403381800007
Keywords in English Gastric cancer; Metastases; Chemotherapy; Radiotherapy; Surgery; Doublet; Triplet; Sequence
Tags EL OK
Tags International impact, Reviewed
Changed by Changed by: Soňa Böhmová, učo 232884. Changed: 26/4/2018 10:34.
Abstract
Metastatic gastric cancer is an incurable disease. Systemic chemotherapy prolongs survival, improves symptom control, and helps maintain a better quality of life of patients with metastatic gastric cancer. HER2 testing of the primary tumor and/or the metastases is warranted before initiation of first line treatment. This review article outlines the indication and clinical data of medical treatment of advanced gastric cancer and highlights aspects of quality of life.
PrintDisplayed: 19/8/2024 12:56